Invasive lobular carcinoma (ILC) of the breast is the second most common histologic subtype of breast cancer. A majority of ILCs are estrogen receptor-positive (ER+) with a diffuse growth pattern that is difficult to detect. Patients with ILC often present at a clinically advanced stage with a low recurrence risk score. The combination of “molecularly low risk” and “clinically high risk” attributed the unique diagnostic and treatment challenges of this type of breast cancer. Dedicated breast positron emission tomography with [18F]fluoroestradiol (FES-dbPET) with high sensitivity and spatial-resolution is a new functional imaging approach to characterize ER+ breast cancers. In this observational study, we hypothesized that FES-dbPET imaging...